Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
luigi.rosa@uniroma1.it
Luigi Rosa
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI SCIENZE ODONTOSTOMATOLOGICHE E MAXILLO-FACCIALI
E-mail:
luigi.rosa@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Effects of usnic acid to prevent infections by creating a protective barrier in an in vitro study
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Iron saturation drives lactoferrin effects on oxidative stress and neurotoxicity induced by HIV-1 tat
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Neutralizing activity of usnic acid and β-cyclodextrins complex against SARS-CoV-2 spike pseudovirus
NATURAL PRODUCT RESEARCH
2023
To boost or to reset: the role of lactoferrin in energy metabolism
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Probiotics-containing mucoadhesive gel for targeting the dysbiosis associated with periodontal diseases
INTERNATIONAL JOURNAL OF DENTISTRY
2022
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
FRONTIERS IN IMMUNOLOGY
2022
Effect of bovine lactoferrin on recurrent urinary tract infections. In vitro and in vivo evidences
BIOMETALS
2022
An overview on in vitro and in vivo antiviral activity of lactoferrin. Its efficacy against SARS-CoV-2 infection
BIOMETALS
2022
Editorial. Nutraceuticals. New perspectives and approaches in human health and disease
FRONTIERS IN PHARMACOLOGY
2022
Evaluation of hepcidin level in covid-19 patients admitted to the intensive care unit
DIAGNOSTICS
2022
Lactoferrin binding to SARS-CoV-2 Spike glycoprotein blocks pseudoviral entry and relieves iron protein dysregulation in several in vitro models
PHARMACEUTICS
2022
Lactoferrin. From the structure to the functional orchestration of iron homeostasis
BIOMETALS
2022
Lactoferrin and oral pathologies: a therapeutic treatment
BIOCHEMISTRY AND CELL BIOLOGY
2021
Lactoferrin against SARS-CoV-2. In vitro and In silico evidences
FRONTIERS IN PHARMACOLOGY
2021
Ambulatory covid-19 patients treated with lactoferrin as a supplementary antiviral agent: A preliminary study
JOURNAL OF CLINICAL MEDICINE
2021
Lactoferrin as antiviral treatment in COVID-19 management. Preliminary evidence
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2021
Challenges in the Microbiological Diagnosis of Implant-Associated Infections: A Summary of the Current Knowledge
FRONTIERS IN MICROBIOLOGY
2021
Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis
CELLULAR SIGNALLING
2020
Lactoferrin's anti-cancer properties. Safety, selectivity, and wide range of action
BIOMOLECULES
2020
Influence of oral administration mode on the efficacy of commercial bovine Lactoferrin against iron and inflammatory homeostasis disorders
BIOMETALS
2020
1
2
3
seguente ›
ultima »
ERC
LS6_5
LS6_9
KET
Life-science technologies & biotechnologies
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma